Intuitive develops, manufactures, and markets robotic-assisted surgical systems designed to enable minimally invasive procedures with greater precision and improved patient outcomes. Founded in 1995, the company has been at the forefront of surgical robotics for nearly three decades, operating worldwide.
The company's core products include the da Vinci surgical system, a robotic platform that allows surgeons to perform minimally invasive operations with enhanced control and visualization, and the Ion endoluminal system, which provides tools for minimally invasive endoluminal procedures. Both systems represent significant engineering efforts in hardware, software, and system integration.
From a technical standpoint, Intuitive's work spans robotic-assisted surgery, minimally invasive surgical technology, and the full cycle of surgical systems development and manufacturing. The company maintains deep collaboration with healthcare professionals globally and focuses on continuous innovation to make surgery more effective and less invasive for patients and care teams. Millions of patients annually undergo procedures that could benefit from the company's technology.
